Gilead Sciences (GILD)

Operating Cash Flow

$13.55B

TTM · Period ending: · USD

GILD logo

GILD Operating Cash Flow

Latest reported$13.55B
GILD TTM Operating Cash Flow (-$20.20M → $13.55B)
High-resolution chart · PNG

GILD operating cash flow history

Trailing twelve months (TTM) · USD. Each value covers four complete reported quarters.

Gilead Sciences Operating Cash Flow — Trailing twelve months (TTM) (USD)
Period endingOperating Cash Flow (USD)
-94,832,000
-62,891,000
-38,202,000
-23,594,000
-35,873,000
-56,246,000
-62,600,000
-70,100,000
-74,560,000
-60,413,000
-55,300,000
-51,200,000
-34,100,000
-29,200,000
-19,900,000
-3,800,000
5,600,000
-6,500,000
-16,500,000
-26,100,000
-34,200,000
-28,800,000
-29,200,000
-26,900,000
-27,400,000
-26,700,000
-25,100,000
-24,900,000
-22,400,000
-20,200,000
-16,800,000
-12,900,000
-8,900,000
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.